Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stocks - JP Morgan, Apple, Walmart, Target Gain in Pre-market; Kroger Tumbles

Published 09/13/2018, 08:28 AM
Updated 09/13/2018, 08:28 AM
© Reuters.  Stocks in focus in pre-market trade on Thursday.

Investing.com - Stocks in focus in pre-market trade Thursday:

• JP Morgan (NYSE:JPM) stock edged forward 0.30% by 8:08 AM ET (12:08 GMT) as U.S. President Donald Trump said that chief executive Jamie Dimon “doesn’t have the aptitude or ‘smarts’” to be president. Trump’s tweet was a response to Dimon’s claim on Wednesday that he could beat Trump in a presidential race because he is “as tough” and “smarter”.

• Apple (NASDAQ:AAPL) stock bounced back 0.75% after shares declined on Wednesday when it revealed new products at its keynote event. Although most analysts commented that the event was in line with expectations, their remarks overall were upbeat.

• Walmart (NYSE:WMT) stock gained 0.31% as its Jet.com e-commerce unit announced it will sell Nike (NYSE:NKE) products and offer more delivery options.

Target (NYSE:TGT) stock rose 0.26% after the company said it would hire 20% more workers for this holiday season and planned on doubling the number of jobs dedicated to orders online.

• Kroger (NYSE:KR) stock tumbled 8.98% as quarterly same-store sales missed estimates.

• Hershey (NYSE:HSY) stock could see movement in the regular session after the company announced it would pay $420 million to acquire Pirate Brands, including the Pirate’s Booty, Smart Puffs and Original Tings brands.

• Impinj (NASDAQ:PI) skyrocketed 37.11% after providing third-quarter guidance on revenue and earnings per share that beat consensus.

• Pivotal Software (NYSE:PVTL) plunged 26.06% despite reporting mostly better-than-expected second quarter results, but a miss on billings. Analysts commented that the stock is still up around 50% since going public earlier this year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Progenics Pharmaceuticals (NASDAQ:PGNX) plummeted 19.86% after announcing that a Phase 3 clinical trial for its prostate cancer imaging agent failed.

• Carnival (NYSE:CCL) stock lost 1.10% as traders worry over possible cruise cancellations due to Hurricane Florence, which is heading right for the U.S. east coast, Tropical Storm Isaac in the eastern Caribbean and a developing tropical depression in the southern Gulf of Mexico.

Latest comments

usdtry
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.